Irbesartan/Hydrochlorothiazide Teva

Irbesartan/Hydrochlorothiazide, the active ingredient in Irbesartan/Hydrochlorothiazide Teva, is an Angiotensin II receptor blocker / Thiazide diuretic presented as a tablet for oral use. It treats hypertension in adult patients who need combined blood‑pressure control. GNH USA supplies Irbesartan/Hydrochlorothiazide Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Irbesartan/Hydrochlorothiazide is used to manage high blood pressure and related conditions by acting on the renin‑angiotensin system and promoting diuresis. - Essential hypertension: lowers systolic and diastolic pressure to target levels. - Hypertension with fluid retention: adds diuretic effect to reduce excess extracellular volume. - Hypertensive patients with renal risk: helps slow progression of kidney disease by controlling pressure and volume.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue or weakness - Increased urination or nocturia - Electrolyte disturbances (e.g., low potassium) - Mild gastrointestinal upset (nausea, abdominal pain)

Serious or Rare Side Effects: - Severe dehydration or electrolyte imbalance - Acute kidney injury or worsening renal function - Hyperkalemia, especially when combined with potassium‑sparing agents - Angioedema or severe allergic reaction - Significant drops in blood pressure (hypotension) - Blood‑cell abnormalities such as leukopenia or thrombocytopenia

Before initiating therapy, clinicians should